nodes	percent_of_prediction	percent_of_DWPC	metapath
Ospemifene—ESR1—hematologic cancer	0.298	1	CbGaD
Ospemifene—CYP2B6—Thiotepa—hematologic cancer	0.0384	0.0756	CbGbCtD
Ospemifene—CYP2C9—Bexarotene—hematologic cancer	0.0245	0.0482	CbGbCtD
Ospemifene—CYP2B6—Ifosfamide—hematologic cancer	0.0218	0.0429	CbGbCtD
Ospemifene—CYP2C9—Idarubicin—hematologic cancer	0.0203	0.0399	CbGbCtD
Ospemifene—CYP2B6—Nilotinib—hematologic cancer	0.0189	0.0372	CbGbCtD
Ospemifene—CYP2C19—Bortezomib—hematologic cancer	0.018	0.0355	CbGbCtD
Ospemifene—CYP2C19—Thalidomide—hematologic cancer	0.0157	0.0309	CbGbCtD
Ospemifene—CYP2C9—Bortezomib—hematologic cancer	0.015	0.0295	CbGbCtD
Ospemifene—CYP2C19—Teniposide—hematologic cancer	0.015	0.0295	CbGbCtD
Ospemifene—CYP3A4—Bexarotene—hematologic cancer	0.0142	0.028	CbGbCtD
Ospemifene—CYP2C19—Ifosfamide—hematologic cancer	0.0138	0.0272	CbGbCtD
Ospemifene—CYP3A4—Busulfan—hematologic cancer	0.0132	0.0261	CbGbCtD
Ospemifene—CYP3A4—Lomustine—hematologic cancer	0.0132	0.0261	CbGbCtD
Ospemifene—CYP2C19—Imatinib—hematologic cancer	0.0132	0.026	CbGbCtD
Ospemifene—CYP2C9—Thalidomide—hematologic cancer	0.0131	0.0257	CbGbCtD
Ospemifene—CYP2B6—Irinotecan—hematologic cancer	0.013	0.0256	CbGbCtD
Ospemifene—CYP2C9—Teniposide—hematologic cancer	0.0125	0.0245	CbGbCtD
Ospemifene—CYP3A4—Thiotepa—hematologic cancer	0.0118	0.0232	CbGbCtD
Ospemifene—CYP2C9—Ifosfamide—hematologic cancer	0.0115	0.0227	CbGbCtD
Ospemifene—CYP2C9—Imatinib—hematologic cancer	0.011	0.0216	CbGbCtD
Ospemifene—CYP2B6—Cisplatin—hematologic cancer	0.0106	0.0209	CbGbCtD
Ospemifene—CYP2C9—Nilotinib—hematologic cancer	0.00998	0.0197	CbGbCtD
Ospemifene—ESR1—ovarian follicle—hematologic cancer	0.00987	0.446	CbGeAlD
Ospemifene—CYP3A4—Methoxsalen—hematologic cancer	0.00916	0.0181	CbGbCtD
Ospemifene—CYP3A4—Bortezomib—hematologic cancer	0.00872	0.0172	CbGbCtD
Ospemifene—CYP2C19—Prednisone—hematologic cancer	0.0087	0.0171	CbGbCtD
Ospemifene—CYP2B6—Dexamethasone—hematologic cancer	0.00855	0.0168	CbGbCtD
Ospemifene—CYP3A4—Daunorubicin—hematologic cancer	0.00834	0.0164	CbGbCtD
Ospemifene—CYP3A4—Cytarabine—hematologic cancer	0.00735	0.0145	CbGbCtD
Ospemifene—CYP3A4—Teniposide—hematologic cancer	0.00724	0.0143	CbGbCtD
Ospemifene—CYP2B6—Doxorubicin—hematologic cancer	0.00709	0.014	CbGbCtD
Ospemifene—CYP3A4—Ifosfamide—hematologic cancer	0.00669	0.0132	CbGbCtD
Ospemifene—CYP3A4—Imatinib—hematologic cancer	0.00639	0.0126	CbGbCtD
Ospemifene—CYP3A4—Ruxolitinib—hematologic cancer	0.00601	0.0118	CbGbCtD
Ospemifene—Haemorrhagic stroke—Dasatinib—hematologic cancer	0.00591	0.0531	CcSEcCtD
Ospemifene—CYP3A4—Nilotinib—hematologic cancer	0.0058	0.0114	CbGbCtD
Ospemifene—CYP3A4—Vinorelbine—hematologic cancer	0.00576	0.0113	CbGbCtD
Ospemifene—CYP2C9—Cisplatin—hematologic cancer	0.00559	0.011	CbGbCtD
Ospemifene—CYP2C19—Dexamethasone—hematologic cancer	0.00543	0.0107	CbGbCtD
Ospemifene—CYP3A4—Triamcinolone—hematologic cancer	0.00526	0.0104	CbGbCtD
Ospemifene—CYP3A4—Dasatinib—hematologic cancer	0.00513	0.0101	CbGbCtD
Ospemifene—CYP3A4—Mitoxantrone—hematologic cancer	0.00507	0.00998	CbGbCtD
Ospemifene—CYP2C9—Dexamethasone—hematologic cancer	0.00452	0.0089	CbGbCtD
Ospemifene—CYP3A4—Betamethasone—hematologic cancer	0.00452	0.0089	CbGbCtD
Ospemifene—CYP3A4—Prednisolone—hematologic cancer	0.00446	0.00878	CbGbCtD
Ospemifene—Haemorrhagic stroke—Bortezomib—hematologic cancer	0.00436	0.0391	CcSEcCtD
Ospemifene—CYP3A4—Prednisone—hematologic cancer	0.00421	0.00829	CbGbCtD
Ospemifene—CYP3A4—Irinotecan—hematologic cancer	0.00399	0.00786	CbGbCtD
Ospemifene—CYP3A4—Vinblastine—hematologic cancer	0.00355	0.00699	CbGbCtD
Ospemifene—CYP3A4—Vincristine—hematologic cancer	0.00349	0.00687	CbGbCtD
Ospemifene—CYP3A4—Etoposide—hematologic cancer	0.0032	0.0063	CbGbCtD
Ospemifene—Deep vein thrombosis—Vorinostat—hematologic cancer	0.00269	0.0242	CcSEcCtD
Ospemifene—CYP3A4—Dexamethasone—hematologic cancer	0.00263	0.00518	CbGbCtD
Ospemifene—CYP3A4—Doxorubicin—hematologic cancer	0.00218	0.00429	CbGbCtD
Ospemifene—Cerebral haemorrhage—Nelarabine—hematologic cancer	0.00215	0.0192	CcSEcCtD
Ospemifene—Neoplasm malignant—Vorinostat—hematologic cancer	0.00192	0.0172	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Busulfan—hematologic cancer	0.00174	0.0156	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Dasatinib—hematologic cancer	0.00165	0.0148	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Imatinib—hematologic cancer	0.00152	0.0136	CcSEcCtD
Ospemifene—Deep vein thrombosis—Dasatinib—hematologic cancer	0.0015	0.0135	CcSEcCtD
Ospemifene—Deep vein thrombosis—Fludarabine—hematologic cancer	0.0015	0.0135	CcSEcCtD
Ospemifene—Cardiovascular disorder—Anagrelide—hematologic cancer	0.00126	0.0113	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Bortezomib—hematologic cancer	0.00122	0.0109	CcSEcCtD
Ospemifene—Deep vein thrombosis—Lenalidomide—hematologic cancer	0.0012	0.0108	CcSEcCtD
Ospemifene—ESR1—hematopoietic system—hematologic cancer	0.00119	0.0538	CbGeAlD
Ospemifene—Cerebral haemorrhage—Thiotepa—hematologic cancer	0.00114	0.0102	CcSEcCtD
Ospemifene—Neoplasm malignant—Busulfan—hematologic cancer	0.00113	0.0101	CcSEcCtD
Ospemifene—CYP2C19—hematopoietic system—hematologic cancer	0.00112	0.0508	CbGeAlD
Ospemifene—Deep vein thrombosis—Bortezomib—hematologic cancer	0.00111	0.00994	CcSEcCtD
Ospemifene—Neoplasm malignant—Procarbazine—hematologic cancer	0.00109	0.00981	CcSEcCtD
Ospemifene—Deep vein thrombosis—Vinorelbine—hematologic cancer	0.00108	0.00971	CcSEcCtD
Ospemifene—Neoplasm malignant—Bexarotene—hematologic cancer	0.00107	0.00961	CcSEcCtD
Ospemifene—Neoplasm malignant—Dasatinib—hematologic cancer	0.00107	0.00961	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Carmustine—hematologic cancer	0.00105	0.00946	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Alitretinoin—hematologic cancer	0.00104	0.00937	CcSEcCtD
Ospemifene—Cardiovascular disorder—Dasatinib—hematologic cancer	0.00104	0.00934	CcSEcCtD
Ospemifene—Neoplasm malignant—Chlorambucil—hematologic cancer	0.00101	0.00908	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Vincristine—hematologic cancer	0.00101	0.00903	CcSEcCtD
Ospemifene—Deep vein thrombosis—Thalidomide—hematologic cancer	0.000999	0.00897	CcSEcCtD
Ospemifene—Neoplasm malignant—Imatinib—hematologic cancer	0.000984	0.00883	CcSEcCtD
Ospemifene—Neoplasm malignant—Cladribine—hematologic cancer	0.000967	0.00868	CcSEcCtD
Ospemifene—Deep vein thrombosis—Ifosfamide—hematologic cancer	0.00094	0.00843	CcSEcCtD
Ospemifene—ESR1—gonad—hematologic cancer	0.000906	0.0409	CbGeAlD
Ospemifene—Neoplasm malignant—Melphalan—hematologic cancer	0.000882	0.00792	CcSEcCtD
Ospemifene—CYP2B6—hematopoietic system—hematologic cancer	0.00088	0.0398	CbGeAlD
Ospemifene—CYP2C9—hematopoietic system—hematologic cancer	0.000871	0.0394	CbGeAlD
Ospemifene—Hot flush—Daunorubicin—hematologic cancer	0.000863	0.00774	CcSEcCtD
Ospemifene—Neoplasm malignant—Lenalidomide—hematologic cancer	0.000858	0.0077	CcSEcCtD
Ospemifene—Menopausal symptoms—Daunorubicin—hematologic cancer	0.000855	0.00767	CcSEcCtD
Ospemifene—Hot flush—Idarubicin—hematologic cancer	0.000828	0.00743	CcSEcCtD
Ospemifene—Menopausal symptoms—Idarubicin—hematologic cancer	0.000821	0.00737	CcSEcCtD
Ospemifene—Neoplasm malignant—Bortezomib—hematologic cancer	0.000789	0.00708	CcSEcCtD
Ospemifene—ESR1—blood—hematologic cancer	0.000789	0.0357	CbGeAlD
Ospemifene—Cardiovascular disorder—Bortezomib—hematologic cancer	0.000767	0.00688	CcSEcCtD
Ospemifene—Hot flush—Busulfan—hematologic cancer	0.000747	0.0067	CcSEcCtD
Ospemifene—CYP2C19—blood—hematologic cancer	0.000745	0.0337	CbGeAlD
Ospemifene—Menopausal symptoms—Busulfan—hematologic cancer	0.00074	0.00664	CcSEcCtD
Ospemifene—Breast disorder—Mercaptopurine—hematologic cancer	0.000739	0.00663	CcSEcCtD
Ospemifene—Neoplasm malignant—Thiotepa—hematologic cancer	0.000736	0.00661	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Ruxolitinib—hematologic cancer	0.000717	0.00643	CcSEcCtD
Ospemifene—ESR1—lung—hematologic cancer	0.000692	0.0313	CbGeAlD
Ospemifene—Muscle spasms—Vorinostat—hematologic cancer	0.000689	0.00618	CcSEcCtD
Ospemifene—Neoplasm malignant—Alitretinoin—hematologic cancer	0.000677	0.00608	CcSEcCtD
Ospemifene—Skin disorder—Ruxolitinib—hematologic cancer	0.000672	0.00603	CcSEcCtD
Ospemifene—Neoplasm malignant—Ifosfamide—hematologic cancer	0.00067	0.00601	CcSEcCtD
Ospemifene—CYP2B6—gonad—hematologic cancer	0.000669	0.0303	CbGeAlD
Ospemifene—CYP3A4—hematopoietic system—hematologic cancer	0.000665	0.03	CbGeAlD
Ospemifene—Cardiovascular disorder—Alitretinoin—hematologic cancer	0.000658	0.00591	CcSEcCtD
Ospemifene—ESR1—testis—hematologic cancer	0.000653	0.0295	CbGeAlD
Ospemifene—Neoplasm malignant—Irinotecan—hematologic cancer	0.000636	0.0057	CcSEcCtD
Ospemifene—Pranlukast—TNF—hematologic cancer	0.000634	0.3	CrCbGaD
Ospemifene—Neoplasm malignant—Gemcitabine—hematologic cancer	0.000619	0.00556	CcSEcCtD
Ospemifene—Breast disorder—Dasatinib—hematologic cancer	0.0006	0.00538	CcSEcCtD
Ospemifene—Connective tissue disorder—Nelarabine—hematologic cancer	0.000586	0.00526	CcSEcCtD
Ospemifene—CYP2B6—blood—hematologic cancer	0.000583	0.0264	CbGeAlD
Ospemifene—CYP2C9—blood—hematologic cancer	0.000577	0.0261	CbGeAlD
Ospemifene—Breast disorder—Nilotinib—hematologic cancer	0.000554	0.00498	CcSEcCtD
Ospemifene—Breast disorder—Imatinib—hematologic cancer	0.000551	0.00495	CcSEcCtD
Ospemifene—Connective tissue disorder—Clofarabine—hematologic cancer	0.000549	0.00492	CcSEcCtD
Ospemifene—Connective tissue disorder—Anagrelide—hematologic cancer	0.000546	0.0049	CcSEcCtD
Ospemifene—Angiopathy—Nelarabine—hematologic cancer	0.000541	0.00486	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—hematologic cancer	0.00052	0.00467	CcSEcCtD
Ospemifene—Cardiovascular disorder—Etoposide—hematologic cancer	0.000514	0.00461	CcSEcCtD
Ospemifene—CYP2B6—lung—hematologic cancer	0.000511	0.0231	CbGeAlD
Ospemifene—Angiopathy—Clofarabine—hematologic cancer	0.000506	0.00454	CcSEcCtD
Ospemifene—Skin disorder—Mechlorethamine—hematologic cancer	0.000488	0.00438	CcSEcCtD
Ospemifene—Muscle spasms—Methoxsalen—hematologic cancer	0.000488	0.00438	CcSEcCtD
Ospemifene—Angiopathy—Idarubicin—hematologic cancer	0.000486	0.00436	CcSEcCtD
Ospemifene—CYP2B6—testis—hematologic cancer	0.000482	0.0218	CbGeAlD
Ospemifene—Breast disorder—Lenalidomide—hematologic cancer	0.000481	0.00431	CcSEcCtD
Ospemifene—Connective tissue disorder—Busulfan—hematologic cancer	0.000475	0.00426	CcSEcCtD
Ospemifene—Breast disorder—Hydroxyurea—hematologic cancer	0.000474	0.00425	CcSEcCtD
Ospemifene—ESR1—lymph node—hematologic cancer	0.000473	0.0214	CbGeAlD
Ospemifene—Muscle spasms—Anagrelide—hematologic cancer	0.000465	0.00417	CcSEcCtD
Ospemifene—Connective tissue disorder—Dasatinib—hematologic cancer	0.000451	0.00405	CcSEcCtD
Ospemifene—Connective tissue disorder—Bexarotene—hematologic cancer	0.000451	0.00405	CcSEcCtD
Ospemifene—Deep vein thrombosis—Methotrexate—hematologic cancer	0.000445	0.00399	CcSEcCtD
Ospemifene—Vaginal discharge—Methotrexate—hematologic cancer	0.000445	0.00399	CcSEcCtD
Ospemifene—Breast disorder—Bortezomib—hematologic cancer	0.000442	0.00397	CcSEcCtD
Ospemifene—CYP3A4—blood—hematologic cancer	0.00044	0.0199	CbGeAlD
Ospemifene—Angiopathy—Busulfan—hematologic cancer	0.000438	0.00393	CcSEcCtD
Ospemifene—Connective tissue disorder—Nilotinib—hematologic cancer	0.000417	0.00374	CcSEcCtD
Ospemifene—Angiopathy—Bexarotene—hematologic cancer	0.000417	0.00374	CcSEcCtD
Ospemifene—Angiopathy—Dasatinib—hematologic cancer	0.000417	0.00374	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—hematologic cancer	0.000417	0.00374	CcSEcCtD
Ospemifene—Vaginal discharge—Epirubicin—hematologic cancer	0.000416	0.00373	CcSEcCtD
Ospemifene—Connective tissue disorder—Imatinib—hematologic cancer	0.000415	0.00372	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Clofarabine—hematologic cancer	0.000411	0.00369	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Anagrelide—hematologic cancer	0.000409	0.00367	CcSEcCtD
Ospemifene—Connective tissue disorder—Cladribine—hematologic cancer	0.000408	0.00366	CcSEcCtD
Ospemifene—Skin disorder—Methoxsalen—hematologic cancer	0.000402	0.00361	CcSEcCtD
Ospemifene—Breast disorder—Thalidomide—hematologic cancer	0.000399	0.00358	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Idarubicin—hematologic cancer	0.000394	0.00354	CcSEcCtD
Ospemifene—Skin disorder—Mercaptopurine—hematologic cancer	0.000391	0.0035	CcSEcCtD
Ospemifene—Skin disorder—Clofarabine—hematologic cancer	0.000385	0.00346	CcSEcCtD
Ospemifene—Angiopathy—Nilotinib—hematologic cancer	0.000385	0.00346	CcSEcCtD
Ospemifene—Vaginal discharge—Doxorubicin—hematologic cancer	0.000385	0.00345	CcSEcCtD
Ospemifene—Muscle spasms—Dasatinib—hematologic cancer	0.000385	0.00345	CcSEcCtD
Ospemifene—Muscle spasms—Bexarotene—hematologic cancer	0.000385	0.00345	CcSEcCtD
Ospemifene—Skin disorder—Anagrelide—hematologic cancer	0.000383	0.00344	CcSEcCtD
Ospemifene—Skin disorder—Pentostatin—hematologic cancer	0.000383	0.00344	CcSEcCtD
Ospemifene—Hyperhidrosis—Daunorubicin—hematologic cancer	0.000383	0.00344	CcSEcCtD
Ospemifene—Hyperhidrosis—Clofarabine—hematologic cancer	0.000383	0.00344	CcSEcCtD
Ospemifene—Angiopathy—Imatinib—hematologic cancer	0.000383	0.00344	CcSEcCtD
Ospemifene—Hyperhidrosis—Pentostatin—hematologic cancer	0.000382	0.00342	CcSEcCtD
Ospemifene—Hyperhidrosis—Anagrelide—hematologic cancer	0.000382	0.00342	CcSEcCtD
Ospemifene—Angiopathy—Cladribine—hematologic cancer	0.000376	0.00338	CcSEcCtD
Ospemifene—Breast disorder—Ifosfamide—hematologic cancer	0.000375	0.00336	CcSEcCtD
Ospemifene—Connective tissue disorder—Melphalan—hematologic cancer	0.000372	0.00334	CcSEcCtD
Ospemifene—Skin disorder—Idarubicin—hematologic cancer	0.00037	0.00332	CcSEcCtD
Ospemifene—Connective tissue disorder—Lenalidomide—hematologic cancer	0.000362	0.00324	CcSEcCtD
Ospemifene—Hyperhidrosis—Teniposide—hematologic cancer	0.000358	0.00321	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Busulfan—hematologic cancer	0.000356	0.00319	CcSEcCtD
Ospemifene—Muscle spasms—Nilotinib—hematologic cancer	0.000355	0.00319	CcSEcCtD
Ospemifene—Muscle spasms—Imatinib—hematologic cancer	0.000353	0.00317	CcSEcCtD
Ospemifene—Toremifene—ESR1—hematologic cancer	0.000341	0.161	CrCbGaD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Bexarotene—hematologic cancer	0.000338	0.00303	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Dasatinib—hematologic cancer	0.000338	0.00303	CcSEcCtD
Ospemifene—Angiopathy—Lenalidomide—hematologic cancer	0.000334	0.00299	CcSEcCtD
Ospemifene—Skin disorder—Busulfan—hematologic cancer	0.000333	0.00299	CcSEcCtD
Ospemifene—Connective tissue disorder—Bortezomib—hematologic cancer	0.000333	0.00298	CcSEcCtD
Ospemifene—Angiopathy—Hydroxyurea—hematologic cancer	0.000329	0.00295	CcSEcCtD
Ospemifene—Connective tissue disorder—Vinorelbine—hematologic cancer	0.000325	0.00291	CcSEcCtD
Ospemifene—Breast disorder—Cisplatin—hematologic cancer	0.000323	0.0029	CcSEcCtD
Ospemifene—Hyperhidrosis—Procarbazine—hematologic cancer	0.000322	0.00289	CcSEcCtD
Ospemifene—Skin disorder—Dasatinib—hematologic cancer	0.000317	0.00284	CcSEcCtD
Ospemifene—Skin disorder—Bexarotene—hematologic cancer	0.000317	0.00284	CcSEcCtD
Ospemifene—Hyperhidrosis—Dasatinib—hematologic cancer	0.000316	0.00283	CcSEcCtD
Ospemifene—Hyperhidrosis—Bexarotene—hematologic cancer	0.000316	0.00283	CcSEcCtD
Ospemifene—Hyperhidrosis—Fludarabine—hematologic cancer	0.000315	0.00282	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Nilotinib—hematologic cancer	0.000312	0.0028	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Imatinib—hematologic cancer	0.000311	0.00279	CcSEcCtD
Ospemifene—Connective tissue disorder—Thiotepa—hematologic cancer	0.00031	0.00278	CcSEcCtD
Ospemifene—Muscle spasms—Lenalidomide—hematologic cancer	0.000308	0.00276	CcSEcCtD
Ospemifene—Angiopathy—Bortezomib—hematologic cancer	0.000307	0.00276	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Cladribine—hematologic cancer	0.000305	0.00274	CcSEcCtD
Ospemifene—Angiopathy—Vinorelbine—hematologic cancer	0.0003	0.00269	CcSEcCtD
Ospemifene—Neoplasm malignant—Epirubicin—hematologic cancer	0.000296	0.00266	CcSEcCtD
Ospemifene—Clomifene—ESR1—hematologic cancer	0.000294	0.139	CrCbGaD
Ospemifene—Skin disorder—Nilotinib—hematologic cancer	0.000293	0.00263	CcSEcCtD
Ospemifene—Hyperhidrosis—Nilotinib—hematologic cancer	0.000292	0.00262	CcSEcCtD
Ospemifene—Skin disorder—Imatinib—hematologic cancer	0.000291	0.00261	CcSEcCtD
Ospemifene—Hyperhidrosis—Imatinib—hematologic cancer	0.00029	0.0026	CcSEcCtD
Ospemifene—Connective tissue disorder—Carmustine—hematologic cancer	0.000288	0.00259	CcSEcCtD
Ospemifene—Cardiovascular disorder—Epirubicin—hematologic cancer	0.000288	0.00258	CcSEcCtD
Ospemifene—Angiopathy—Thiotepa—hematologic cancer	0.000286	0.00257	CcSEcCtD
Ospemifene—Skin disorder—Cladribine—hematologic cancer	0.000286	0.00257	CcSEcCtD
Ospemifene—Hyperhidrosis—Cladribine—hematologic cancer	0.000285	0.00256	CcSEcCtD
Ospemifene—Muscle spasms—Bortezomib—hematologic cancer	0.000283	0.00254	CcSEcCtD
Ospemifene—Connective tissue disorder—Ifosfamide—hematologic cancer	0.000282	0.00253	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Melphalan—hematologic cancer	0.000278	0.0025	CcSEcCtD
Ospemifene—Angiopathy—Thalidomide—hematologic cancer	0.000277	0.00249	CcSEcCtD
Ospemifene—Connective tissue disorder—Vincristine—hematologic cancer	0.000275	0.00247	CcSEcCtD
Ospemifene—Neoplasm malignant—Doxorubicin—hematologic cancer	0.000274	0.00246	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Lenalidomide—hematologic cancer	0.000271	0.00243	CcSEcCtD
Ospemifene—Connective tissue disorder—Irinotecan—hematologic cancer	0.000268	0.0024	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—hematologic cancer	0.000267	0.0024	CcSEcCtD
Ospemifene—Cardiovascular disorder—Doxorubicin—hematologic cancer	0.000267	0.00239	CcSEcCtD
Ospemifene—Angiopathy—Alitretinoin—hematologic cancer	0.000264	0.00236	CcSEcCtD
Ospemifene—Skin disorder—Melphalan—hematologic cancer	0.000261	0.00234	CcSEcCtD
Ospemifene—Connective tissue disorder—Gemcitabine—hematologic cancer	0.000261	0.00234	CcSEcCtD
Ospemifene—Angiopathy—Ifosfamide—hematologic cancer	0.00026	0.00234	CcSEcCtD
Ospemifene—Muscle spasms—Thalidomide—hematologic cancer	0.000256	0.00229	CcSEcCtD
Ospemifene—Angiopathy—Vincristine—hematologic cancer	0.000254	0.00228	CcSEcCtD
Ospemifene—Skin disorder—Lenalidomide—hematologic cancer	0.000254	0.00228	CcSEcCtD
Ospemifene—Hyperhidrosis—Lenalidomide—hematologic cancer	0.000253	0.00227	CcSEcCtD
Ospemifene—Skin disorder—Hydroxyurea—hematologic cancer	0.00025	0.00225	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Bortezomib—hematologic cancer	0.000249	0.00224	CcSEcCtD
Ospemifene—Angiopathy—Irinotecan—hematologic cancer	0.000247	0.00222	CcSEcCtD
Ospemifene—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000244	0.115	CrCbGaD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—hematologic cancer	0.000243	0.00218	CcSEcCtD
Ospemifene—Connective tissue disorder—Cisplatin—hematologic cancer	0.000243	0.00218	CcSEcCtD
Ospemifene—Angiopathy—Gemcitabine—hematologic cancer	0.000241	0.00216	CcSEcCtD
Ospemifene—Skin disorder—Bortezomib—hematologic cancer	0.000234	0.0021	CcSEcCtD
Ospemifene—Hyperhidrosis—Bortezomib—hematologic cancer	0.000233	0.00209	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—hematologic cancer	0.000232	0.00208	CcSEcCtD
Ospemifene—Muscle spasms—Irinotecan—hematologic cancer	0.000228	0.00205	CcSEcCtD
Ospemifene—Skin disorder—Vinorelbine—hematologic cancer	0.000228	0.00205	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—hematologic cancer	0.000225	0.00202	CcSEcCtD
Ospemifene—Skin disorder—Thiotepa—hematologic cancer	0.000218	0.00195	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—hematologic cancer	0.000214	0.00192	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—hematologic cancer	0.000211	0.0019	CcSEcCtD
Ospemifene—Skin disorder—Thalidomide—hematologic cancer	0.000211	0.00189	CcSEcCtD
Ospemifene—Hyperhidrosis—Thalidomide—hematologic cancer	0.00021	0.00188	CcSEcCtD
Ospemifene—Muscle spasms—Cisplatin—hematologic cancer	0.000207	0.00186	CcSEcCtD
Ospemifene—Angiopathy—Etoposide—hematologic cancer	0.000206	0.00185	CcSEcCtD
Ospemifene—Skin disorder—Alitretinoin—hematologic cancer	0.0002	0.0018	CcSEcCtD
Ospemifene—Hyperhidrosis—Alitretinoin—hematologic cancer	0.0002	0.00179	CcSEcCtD
Ospemifene—Skin disorder—Ifosfamide—hematologic cancer	0.000198	0.00178	CcSEcCtD
Ospemifene—Hyperhidrosis—Ifosfamide—hematologic cancer	0.000197	0.00177	CcSEcCtD
Ospemifene—Hot flush—Epirubicin—hematologic cancer	0.000196	0.00176	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.000195	0.00175	CcSEcCtD
Ospemifene—Menopausal symptoms—Epirubicin—hematologic cancer	0.000195	0.00175	CcSEcCtD
Ospemifene—Hyperhidrosis—Vincristine—hematologic cancer	0.000192	0.00173	CcSEcCtD
Ospemifene—Muscle spasms—Etoposide—hematologic cancer	0.00019	0.0017	CcSEcCtD
Ospemifene—Skin disorder—Mitoxantrone—hematologic cancer	0.000188	0.00169	CcSEcCtD
Ospemifene—Hyperhidrosis—Irinotecan—hematologic cancer	0.000187	0.00168	CcSEcCtD
Ospemifene—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.000187	0.00168	CcSEcCtD
Ospemifene—Skin disorder—Gemcitabine—hematologic cancer	0.000183	0.00164	CcSEcCtD
Ospemifene—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000182	0.00164	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000182	0.00163	CcSEcCtD
Ospemifene—Hot flush—Doxorubicin—hematologic cancer	0.000182	0.00163	CcSEcCtD
Ospemifene—Menopausal symptoms—Doxorubicin—hematologic cancer	0.00018	0.00162	CcSEcCtD
Ospemifene—Breast disorder—Methotrexate—hematologic cancer	0.000177	0.00159	CcSEcCtD
Ospemifene—Skin disorder—Cisplatin—hematologic cancer	0.000171	0.00153	CcSEcCtD
Ospemifene—Hyperhidrosis—Cisplatin—hematologic cancer	0.00017	0.00153	CcSEcCtD
Ospemifene—Angiopathy—Dexamethasone—hematologic cancer	0.000169	0.00152	CcSEcCtD
Ospemifene—Angiopathy—Betamethasone—hematologic cancer	0.000169	0.00152	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000167	0.0015	CcSEcCtD
Ospemifene—Breast disorder—Epirubicin—hematologic cancer	0.000166	0.00149	CcSEcCtD
Ospemifene—Connective tissue disorder—Prednisone—hematologic cancer	0.00016	0.00143	CcSEcCtD
Ospemifene—Skin disorder—Etoposide—hematologic cancer	0.000156	0.0014	CcSEcCtD
Ospemifene—Hyperhidrosis—Etoposide—hematologic cancer	0.000156	0.0014	CcSEcCtD
Ospemifene—Breast disorder—Doxorubicin—hematologic cancer	0.000154	0.00138	CcSEcCtD
Ospemifene—Hyperhidrosis—Prednisolone—hematologic cancer	0.000154	0.00138	CcSEcCtD
Ospemifene—Angiopathy—Prednisone—hematologic cancer	0.000147	0.00132	CcSEcCtD
Ospemifene—Toremifene—ABCB1—hematologic cancer	0.000145	0.0684	CrCbGaD
Ospemifene—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000141	0.00127	CcSEcCtD
Ospemifene—Tamoxifen—ABCG2—hematologic cancer	0.000139	0.0657	CrCbGaD
Ospemifene—Tamoxifen—ESR1—hematologic cancer	0.000136	0.0643	CrCbGaD
Ospemifene—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000128	0.00115	CcSEcCtD
Ospemifene—Hyperhidrosis—Betamethasone—hematologic cancer	0.000128	0.00115	CcSEcCtD
Ospemifene—Clomifene—ABCB1—hematologic cancer	0.000125	0.0591	CrCbGaD
Ospemifene—Connective tissue disorder—Epirubicin—hematologic cancer	0.000125	0.00112	CcSEcCtD
Ospemifene—Angiopathy—Methotrexate—hematologic cancer	0.000123	0.00111	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.00012	0.00107	CcSEcCtD
Ospemifene—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000116	0.00104	CcSEcCtD
Ospemifene—Angiopathy—Epirubicin—hematologic cancer	0.000115	0.00103	CcSEcCtD
Ospemifene—Skin disorder—Prednisone—hematologic cancer	0.000112	0.00101	CcSEcCtD
Ospemifene—Hyperhidrosis—Prednisone—hematologic cancer	0.000112	0.001	CcSEcCtD
Ospemifene—Angiopathy—Doxorubicin—hematologic cancer	0.000107	0.000957	CcSEcCtD
Ospemifene—Muscle spasms—Epirubicin—hematologic cancer	0.000106	0.000955	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.0001	0.000897	CcSEcCtD
Ospemifene—Muscle spasms—Doxorubicin—hematologic cancer	9.84e-05	0.000883	CcSEcCtD
Ospemifene—Skin disorder—Methotrexate—hematologic cancer	9.37e-05	0.000841	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.36e-05	0.000839	CcSEcCtD
Ospemifene—Hyperhidrosis—Methotrexate—hematologic cancer	9.33e-05	0.000837	CcSEcCtD
Ospemifene—Skin disorder—Epirubicin—hematologic cancer	8.77e-05	0.000787	CcSEcCtD
Ospemifene—Hyperhidrosis—Epirubicin—hematologic cancer	8.73e-05	0.000783	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.66e-05	0.000777	CcSEcCtD
Ospemifene—Skin disorder—Doxorubicin—hematologic cancer	8.12e-05	0.000728	CcSEcCtD
Ospemifene—Hyperhidrosis—Doxorubicin—hematologic cancer	8.08e-05	0.000725	CcSEcCtD
Ospemifene—Tamoxifen—ABCB1—hematologic cancer	5.78e-05	0.0273	CrCbGaD
Ospemifene—ESR1—Signaling Pathways—PARP1—hematologic cancer	9.85e-06	0.000169	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—GSTT1—hematologic cancer	9.7e-06	0.000166	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FBXW7—hematologic cancer	9.69e-06	0.000166	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—IDH1—hematologic cancer	9.56e-06	0.000164	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.56e-06	0.000164	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ARNTL—hematologic cancer	9.53e-06	0.000163	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CXCR4—hematologic cancer	9.51e-06	0.000163	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—HDAC2—hematologic cancer	9.51e-06	0.000163	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CDA—hematologic cancer	9.49e-06	0.000162	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—SDC1—hematologic cancer	9.48e-06	0.000162	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—TXN—hematologic cancer	9.46e-06	0.000162	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ABCC3—hematologic cancer	9.46e-06	0.000162	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—GSTO1—hematologic cancer	9.46e-06	0.000162	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—MYC—hematologic cancer	9.4e-06	0.000161	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CA9—hematologic cancer	9.27e-06	0.000159	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ACP5—hematologic cancer	9.27e-06	0.000159	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CBL—hematologic cancer	9.26e-06	0.000158	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—SPHK1—hematologic cancer	9.25e-06	0.000158	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL3—hematologic cancer	9.17e-06	0.000157	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NCOR2—hematologic cancer	9.15e-06	0.000157	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PC—hematologic cancer	9.14e-06	0.000156	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PTPN1—hematologic cancer	9.01e-06	0.000154	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—UGT1A1—hematologic cancer	8.89e-06	0.000152	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—MAPK14—hematologic cancer	8.87e-06	0.000152	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—RASGRP1—hematologic cancer	8.87e-06	0.000152	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—HSP90AA1—hematologic cancer	8.84e-06	0.000151	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—SYK—hematologic cancer	8.84e-06	0.000151	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—GBA—hematologic cancer	8.82e-06	0.000151	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.82e-06	0.000151	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—IDH1—hematologic cancer	8.72e-06	0.000149	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—SLC22A1—hematologic cancer	8.65e-06	0.000148	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CRABP1—hematologic cancer	8.65e-06	0.000148	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.62e-06	0.000147	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—TXN—hematologic cancer	8.62e-06	0.000147	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.62e-06	0.000147	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—STAT1—hematologic cancer	8.52e-06	0.000146	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.44e-06	0.000144	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.43e-06	0.000144	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—NOTCH1—hematologic cancer	8.41e-06	0.000144	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—NUP98—hematologic cancer	8.16e-06	0.00014	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.11e-06	0.000139	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—MTAP—hematologic cancer	8.07e-06	0.000138	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—NQO1—hematologic cancer	8.06e-06	0.000138	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CD44—hematologic cancer	8.06e-06	0.000138	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—GRB2—hematologic cancer	7.97e-06	0.000136	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PDGFA—hematologic cancer	7.95e-06	0.000136	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.92e-06	0.000136	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.92e-06	0.000136	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.89e-06	0.000135	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.89e-06	0.000135	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—NUP214—hematologic cancer	7.87e-06	0.000135	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—KITLG—hematologic cancer	7.84e-06	0.000134	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.79e-06	0.000133	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—MTR—hematologic cancer	7.71e-06	0.000132	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.71e-06	0.000132	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.69e-06	0.000131	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—STAT5A—hematologic cancer	7.66e-06	0.000131	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CYCS—hematologic cancer	7.63e-06	0.000131	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—CREBBP—hematologic cancer	7.63e-06	0.00013	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CDKN2B—hematologic cancer	7.6e-06	0.00013	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	7.58e-06	0.00013	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ENO2—hematologic cancer	7.56e-06	0.000129	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NUP98—hematologic cancer	7.44e-06	0.000127	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CD86—hematologic cancer	7.35e-06	0.000126	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.33e-06	0.000125	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—HES1—hematologic cancer	7.25e-06	0.000124	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.23e-06	0.000124	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.23e-06	0.000124	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.22e-06	0.000123	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—NCOR1—hematologic cancer	7.2e-06	0.000123	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—FHL2—hematologic cancer	7.19e-06	0.000123	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NUP214—hematologic cancer	7.17e-06	0.000123	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—SDC1—hematologic cancer	7.17e-06	0.000123	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FGF1—hematologic cancer	7.12e-06	0.000122	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CSF2—hematologic cancer	7.12e-06	0.000122	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.1e-06	0.000121	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—AGRN—hematologic cancer	7.05e-06	0.000121	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—MTR—hematologic cancer	7.03e-06	0.00012	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.03e-06	0.00012	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FOXO1—hematologic cancer	7.02e-06	0.00012	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PDGFRB—hematologic cancer	7.01e-06	0.00012	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PDGFRA—hematologic cancer	6.9e-06	0.000118	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ENO2—hematologic cancer	6.89e-06	0.000118	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—JAK1—hematologic cancer	6.88e-06	0.000118	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PRKCG—hematologic cancer	6.88e-06	0.000118	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.85e-06	0.000117	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.76e-06	0.000116	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—GSTP1—hematologic cancer	6.73e-06	0.000115	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—HMMR—hematologic cancer	6.69e-06	0.000114	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—IDH2—hematologic cancer	6.69e-06	0.000114	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.69e-06	0.000114	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.58e-06	0.000113	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—SDC1—hematologic cancer	6.53e-06	0.000112	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.46e-06	0.000111	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL2RA—hematologic cancer	6.42e-06	0.00011	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—ABCB1—hematologic cancer	6.37e-06	0.000109	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TERT—hematologic cancer	6.35e-06	0.000109	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.29e-06	0.000108	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.24e-06	0.000107	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PDGFB—hematologic cancer	6.2e-06	0.000106	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—NCOR1—hematologic cancer	6.18e-06	0.000106	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—GSTM1—hematologic cancer	6.18e-06	0.000106	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.16e-06	0.000105	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CA9—hematologic cancer	6.12e-06	0.000105	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ACP5—hematologic cancer	6.12e-06	0.000105	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CD44—hematologic cancer	6.09e-06	0.000104	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—NQO1—hematologic cancer	6.09e-06	0.000104	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TSC2—hematologic cancer	6.06e-06	0.000104	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.04e-06	0.000103	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.97e-06	0.000102	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.89e-06	0.000101	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FGFR3—hematologic cancer	5.83e-06	9.97e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MAPK14—hematologic cancer	5.77e-06	9.87e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CYCS—hematologic cancer	5.77e-06	9.86e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—IDH1—hematologic cancer	5.75e-06	9.84e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.73e-06	9.8e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.69e-06	9.73e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.69e-06	9.73e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—TXN—hematologic cancer	5.69e-06	9.73e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FN1—hematologic cancer	5.59e-06	9.56e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.56e-06	9.52e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NQO1—hematologic cancer	5.56e-06	9.5e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CD44—hematologic cancer	5.56e-06	9.5e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—NFKBIA—hematologic cancer	5.52e-06	9.45e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—BAD—hematologic cancer	5.52e-06	9.45e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—NOTCH1—hematologic cancer	5.47e-06	9.36e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—MTHFR—hematologic cancer	5.46e-06	9.34e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.44e-06	9.31e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CD80—hematologic cancer	5.36e-06	9.17e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—KIT—hematologic cancer	5.35e-06	9.15e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PIK3CG—hematologic cancer	5.35e-06	9.15e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.35e-06	9.14e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CYCS—hematologic cancer	5.26e-06	8.99e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PTPN11—hematologic cancer	5.26e-06	8.99e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.22e-06	8.94e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.2e-06	8.9e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.2e-06	8.9e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.16e-06	8.82e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CREB1—hematologic cancer	5.09e-06	8.71e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.08e-06	8.69e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.07e-06	8.67e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—BRAF—hematologic cancer	5.03e-06	8.6e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCL2—hematologic cancer	4.98e-06	8.52e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL6R—hematologic cancer	4.97e-06	8.5e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CREBBP—hematologic cancer	4.96e-06	8.48e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.92e-06	8.41e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NUP98—hematologic cancer	4.91e-06	8.4e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.81e-06	8.23e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.77e-06	8.15e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.77e-06	8.15e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	4.73e-06	8.1e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NUP214—hematologic cancer	4.73e-06	8.09e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	4.7e-06	8.04e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.7e-06	8.04e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.67e-06	7.99e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.67e-06	7.99e-05	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—MAPK3—hematologic cancer	4.65e-06	7.96e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.64e-06	7.93e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—MTR—hematologic cancer	4.64e-06	7.93e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.63e-06	7.93e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PIK3CG—hematologic cancer	4.59e-06	7.85e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ENO2—hematologic cancer	4.55e-06	7.78e-05	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—MYC—hematologic cancer	4.53e-06	7.74e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FGF2—hematologic cancer	4.5e-06	7.7e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.48e-06	7.67e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	4.44e-06	7.6e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.41e-06	7.54e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.39e-06	7.5e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—JAK2—hematologic cancer	4.32e-06	7.38e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—SDC1—hematologic cancer	4.31e-06	7.37e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.26e-06	7.28e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.26e-06	7.28e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CREBBP—hematologic cancer	4.26e-06	7.28e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MDM2—hematologic cancer	4.21e-06	7.21e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.13e-06	7.06e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	4.1e-06	7.01e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MTOR—hematologic cancer	4.1e-06	7.01e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PIK3CD—hematologic cancer	4.03e-06	6.9e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—ALB—hematologic cancer	3.98e-06	6.81e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	3.85e-06	6.58e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.81e-06	6.52e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CASP3—hematologic cancer	3.77e-06	6.45e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL2—hematologic cancer	3.76e-06	6.44e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.76e-06	6.44e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCND1—hematologic cancer	3.67e-06	6.28e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CD44—hematologic cancer	3.66e-06	6.27e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NQO1—hematologic cancer	3.66e-06	6.27e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—JUN—hematologic cancer	3.66e-06	6.26e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.64e-06	6.22e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	3.55e-06	6.07e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PTEN—hematologic cancer	3.54e-06	6.06e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.52e-06	6.01e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.47e-06	5.93e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CYCS—hematologic cancer	3.47e-06	5.93e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MAPK8—hematologic cancer	3.47e-06	5.93e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.45e-06	5.89e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—EP300—hematologic cancer	3.38e-06	5.78e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.32e-06	5.67e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—SRC—hematologic cancer	3.28e-06	5.62e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.22e-06	5.5e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—VEGFA—hematologic cancer	3.2e-06	5.47e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—STAT3—hematologic cancer	3.17e-06	5.42e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.16e-06	5.41e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—NRAS—hematologic cancer	3.16e-06	5.41e-05	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—AKT1—hematologic cancer	3.14e-06	5.37e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.06e-06	5.23e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.05e-06	5.21e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PTEN—hematologic cancer	3.04e-06	5.2e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MAPK3—hematologic cancer	3.03e-06	5.18e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ALB—hematologic cancer	3.01e-06	5.15e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MYC—hematologic cancer	2.94e-06	5.03e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TGFB1—hematologic cancer	2.94e-06	5.02e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.93e-06	5.01e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—EP300—hematologic cancer	2.9e-06	4.96e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.89e-06	4.95e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.88e-06	4.92e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.81e-06	4.8e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.81e-06	4.8e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.78e-06	4.75e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ALB—hematologic cancer	2.74e-06	4.69e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—KRAS—hematologic cancer	2.72e-06	4.65e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.66e-06	4.55e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.63e-06	4.49e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	2.5e-06	4.27e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.48e-06	4.25e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.42e-06	4.14e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TP53—hematologic cancer	2.42e-06	4.13e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—HRAS—hematologic cancer	2.31e-06	3.95e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PTEN—hematologic cancer	2.3e-06	3.93e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL6—hematologic cancer	2.21e-06	3.78e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—EP300—hematologic cancer	2.19e-06	3.75e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.14e-06	3.67e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PTEN—hematologic cancer	2.09e-06	3.58e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.09e-06	3.57e-05	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—AKT1—hematologic cancer	2.04e-06	3.49e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—EP300—hematologic cancer	2e-06	3.42e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.93e-06	3.31e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.83e-06	3.14e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ALB—hematologic cancer	1.81e-06	3.1e-05	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—AKT1—hematologic cancer	1.75e-06	3e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.73e-06	2.96e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.62e-06	2.77e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.6e-06	2.73e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.48e-06	2.53e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PTEN—hematologic cancer	1.38e-06	2.36e-05	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—AKT1—hematologic cancer	1.32e-06	2.26e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—EP300—hematologic cancer	1.32e-06	2.25e-05	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—AKT1—hematologic cancer	1.21e-06	2.06e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.74e-07	1.67e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—AKT1—hematologic cancer	7.96e-07	1.36e-05	CbGpPWpGaD
